Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Neuland Laboratories Ltd

Healthcare | Small Cap

Neuland Laboratories Ltd Health Insights
Health Score : 7.84Health Score : 7.84

Neuland Laboratories Ltd. demonstrates exceptional financial health, driven by outstanding profitability and remarkable growth. The company excels at converting revenue into profit and is expanding its sales and earnings at a very high rate. Its financial foundation is extremely solid, with very little reliance on debt, which significantly reduces long-term risks. Shareholders have benefited from strong growth in earnings and dividends. The main area of concern is operational efficiency; the company is slow in selling its inventory and collecting payments, and it does not generate as much sales from its assets as it could. While it has an adequate ability to meet its short-term bills, its cash generation from operations is a weaker point. The outlook is positive due to strong growth and profitability, but its future performance also depends on how well it manages its assets.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Neuland Laboratories Ltd Health Insights
Health Score : 7.84Health Score : 7.84

Neuland Laboratories Ltd. demonstrates exceptional financial health, driven by outstanding profitability and remarkable growth. The company excels at converting revenue into profit and is expanding its sales and earnings at a very high rate. Its financial foundation is extremely solid, with very little reliance on debt, which significantly reduces long-term risks. Shareholders have benefited from strong growth in earnings and dividends. The main area of concern is operational efficiency; the company is slow in selling its inventory and collecting payments, and it does not generate as much sales from its assets as it could. While it has an adequate ability to meet its short-term bills, its cash generation from operations is a weaker point. The outlook is positive due to strong growth and profitability, but its future performance also depends on how well it manages its assets.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Highly Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Highly Overvalued

P/E RATIO (TTM)

61.29

Highly Overvalued

Industry Median

28.62

Highly Overvalued
Highly Overvalued

Small Cap Median

27.17

Highly Overvalued

P/E RATIO

61.14

P/B RATIO

11.87

Highly Overvalued

Industry Median

3.17

Highly Overvalued
Highly Overvalued

Small Cap Median

2.62

Highly Overvalued

P/S RATIO

10.97

Highly Overvalued

Industry Median

3.42

Highly Overvalued
Highly Overvalued

Small Cap Median

2.55

Highly Overvalued

Others

Neutral

PEG RATIO

1.58

Neutral
Overvalued

EV/EBITDA RATIO

36.55

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹17345 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is demonstrating excellent and robust growth across the board. It has achieved very high rates of expansion in its revenue, operating profits, and net income. This rapid growth is a clear indicator of strong market demand for its offerings and successful execution of its business strategy. While projections show some volatility with a dip in 2025, the overall trend points to a powerful growth trajectory, which is a key strength.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate1.4925.2430.9-5.2636.97
Operating Profit Growth Rate-2.0489.5869.6-28.5173.41
Earnings Per Share (EPS) Growth-20.86156.2383.52-13.3239.94
Asset Growth Rate4.3814.2416.0118.9334.4
Net Income Growth Rate-20.99156.2582.93-13.3340
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.40

From a shareholder's perspective, the company's financial performance is strong. It delivers excellent earnings and cash flow per share, and its intrinsic book value is growing impressively. Dividend payments are also very healthy. The one area that stands out negatively is the significant and rising capital expenditure. While this represents a large use of cash, it is also a necessary investment to fuel the company's high-growth strategy, which is a positive for the long-term outlook.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
ExcellentDividend Per Share (DPS)Excellent
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)50126.92230.77160280
Cash Earnings Per Share (Cash EPS)86.92166.92276.92250.77350.77
Book Value Per Share646.92764.62986.921173.081442.31
Dividend Per Share (DPS)4.9710.214.0312.1634.05
Capital Expenditures (CapEx)9865143205396
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability is excellent across all measures. It is highly effective at turning sales into profits, as shown by its strong margins. Furthermore, it generates outstanding returns on the capital invested by shareholders and lenders. This superior ability to generate profit and provide high returns on investment is a core strength of the business, indicating efficient management, strong pricing power, or a significant competitive advantage in its market.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin9.9918.4725.8517.9423.83
Return on Capital Employed (ROCE)1021331927
Return on Equity (ROE)7.6116.523.3817.0519.41
Return on Assets (ROA)10.4117.2825.2615.1819.59
Operating Margin15.1422.9229.722.4128.37
Net Margin6.7313.7719.2417.617.99
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.67

The company's operational efficiency is a significant area of weakness. It appears to be struggling to generate sufficient revenue from its assets, including its plant, equipment, and inventory. The process of converting inventory to sales and collecting cash from customers is slow. This indicates that a substantial amount of capital is tied up in operations, which can hinder financial flexibility and overall profitability, despite the company's strong performance in other areas.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.241.571.891.551.72
Inventory Turnover Ratio3.343.573.683.293.44
Receivables Turnover Ratio4.2144.244.284.72
Days Sales in Inventory Ratio109.28102.2499.18110.94106.1
Receivable Days86.791.2586.0885.2877.33
Capital Turnover Ratio11.111.160.90.94
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company's capacity to meet its financial obligations is outstanding. It generates more than enough earnings to comfortably cover its interest payments, indicating a very low risk of default. Furthermore, its profits provide a very strong cushion for its dividend payments to shareholders. This combination of high coverage for both debt and dividends signals exceptional financial strength and reliability, which is highly favorable for both creditors and investors.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio6.8617.6229.6444.2521.38
Equity Dividend Coverage Ratio1012.516.6716.678.33
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's long-term financial stability is exceptional. It has a very low reliance on debt, with the vast majority of its operations funded by owner's equity. This conservative capital structure signifies extremely low financial risk and a very strong capacity to handle its long-term obligations. Creditors and investors can view the company as highly stable and creditworthy, with substantial capacity to take on new debt for future growth if needed.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.120.080.040.070.12
Debt to Equity Ratio0.140.090.040.080.14
Equity Ratio0.880.920.960.930.88
Debt To Asset Ratio0.080.050.030.050.09
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 6.28

The company's ability to meet its short-term financial obligations is adequate. It has a good capacity to cover immediate debts with its more liquid assets, which is a positive sign. However, its position is not overwhelmingly strong, as its cash reserves are average and the cash generated from core operations is on the weaker side. This indicates a manageable short-term financial standing but without a large safety cushion, suggesting a balance between holding cash and investing it back into the business.

AverageCurrent RatiosAverage
GoodQuick RatiosGood
AverageCash RatiosAverage
WeakOperating Cash Flow RatiosWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.381.551.961.971.95
Quick Ratio0.7611.241.261.31
Cash Ratio0.050.120.240.480.45
Operating Cash Flow Ratio0.140.470.530.580.44
01.

Current Ratios

02.

Quick Ratios

03.

Cash Ratios

04.

Operating Cash Flow Ratios

Peer Comparison With 16 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1J B Chemicals & Pharmaceuticals Ltd8.1449.64Overvalued1107.0041.98709.00
2Gland Pharma Ltd7.9135.27Overvalued1630.0078.881027.00
3Neuland Laboratories Ltd7.8461.14Highly Overvalued574.00283.01364.00
4Granules India Ltd7.7332.77Highly Overvalued1185.0016.17595.00
5Ajanta Pharma Ltd7.7236.27Neutral1395.0075.781056.00
6Alembic Pharmaceuticals Ltd7.5422.23Undervalued1118.0032.58671.00
7Syngene International Ltd7.4456.08Overvalued918.007.55317.00
8Emcure Pharmaceuticals Ltd7.4036.42Neutral1865.0038.66941.00
9ERIS Lifesciences Ltd7.1532.39Neutral1120.0017.61648.00
10Piramal Pharma Ltd5.83-64.86Neutral922.005.27-326.00
11Jubilant Pharmova Ltd5.7138.62Neutral1260.001.25398.00
12Natco Pharma Ltd5.6911.22Neutral1436.0071.551418.00
13Wockhardt Ltd5.07153.40Neutral652.0019.51199.00
14Pfizer Ltd3.4545.16Neutral-82.00157.92300.00
15Procter & Gamble Health Ltd3.4531.71Neutral457.00196.94327.00
16Sanofi India Ltd3.4518.59Neutral491.00134.52413.00
Management Assessment Summary
GreenStrong Management

Management demonstrates outstanding effectiveness, evidenced by explosive growth in sales and profits, and a dramatic improvement in margins (OPM up to 30%) and return metrics (ROCE at 33%). Prudent capital management is clear from the significant debt reduction (D/E ratio of 0.07) and strong interest coverage (33x). This financial turnaround has attracted significant FII investment. The primary weaknesses are high quarterly earnings volatility, a low dividend payout, and a declining promoter stake. However, the sheer scale of financial performance improvement and strengthening of the balance sheet are the dominant factors, pointing to highly effective management.

[{'Category': 'PROS', 'Metric': 'Strong Profit Growth', 'Value': '83% YoY', 'Assessment': 'Outstanding'}, {'Category': 'PROS', 'Metric': 'Improving Capital Efficiency', 'Value': 'ROCE 33%', 'Assessment': 'Excellent'}, {'Category': 'PROS', 'Metric': 'Excellent Debt Management', 'Value': 'D/E 0.07', 'Assessment': 'Very Strong'}, {'Category': 'PROS', 'Metric': 'Increasing Institutional Holding', 'Value': 'FIIs +6.29% YoY', 'Assessment': 'Strong'}, {'Category': 'CONS', 'Metric': 'Declining Promoter Holding', 'Value': '-3.4% YoY', 'Assessment': 'Weak'}, {'Category': 'CONS', 'Metric': 'Volatile Quarterly Performance', 'Value': 'Profit growth from +521% to -63%', 'Assessment': 'Volatile'}, {'Category': 'CONS', 'Metric': 'Low Dividend Payout', 'Value': '6%', 'Assessment': 'Weak'}]

ExcellentFinancial Performance & GrowthExcellent
ExcellentCapital Efficiency & ReturnsExcellent
ExcellentFinancial Health & PrudenceExcellent
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The overall risk profile is mixed. Financial risk is very low, supported by a robust balance sheet with minimal debt (D/E 0.07), strong cash flow generation, and excellent interest coverage. The company consistently converts profits into cash, indicating high-quality earnings with no apparent accounting red flags. However, a significant operational risk exists, highlighted by the extreme volatility in quarterly sales and profit growth. This unpredictability suggests a lumpy revenue model, possibly due to customer concentration or project-based business, which can impact earnings stability. Furthermore, the steady decline in promoter shareholding introduces a strategic risk related to long-term ownership alignment, even as rising FII interest provides a positive counterbalance.

ExcellentAccounting QualityExcellent
WeakOperational Risk (Earnings Volatility)Weak
01.

Accounting Quality

02.

Operational Risk (Earnings Volatility)

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1017295.10Bearish
  3. SMA 2017157.40Bullish
  4. SMA 5017049.52Bullish
  5. EMA 1017273.06Bullish
  6. EMA 2017189.28Bullish
  7. EMA 5017089.59Bullish
  8. DEMA 1017356.05Bearish
  9. DEMA 2017315.28Bearish
  10. DEMA 5017171.90Bullish
  11. TEMA 1017345.24Bearish
  12. TEMA 2017383.58Bearish
  13. TEMA 5017224.20Bullish
  14. MACD98.70Bullish
  15. ADX40.67Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI58.18Neutral
  3. CCI70.12Neutral
  4. ROC 90.09Bullish
  5. ROC 141.59Bullish
  6. ROC 253.45Bullish
  7. Stoch K75.10Neutral
  8. Stoch D77.32Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper17501.66Neutral
  3. BB Middle17157.40Neutral
  4. BB Lower16813.14Neutral
  5. ATR157.70High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI70.10Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1017207.80Bullish
  3. SMA 2017049.20Bullish
  4. SMA 5017024.70Bullish
  5. EMA 1017206.94Bullish
  6. EMA 2017124.85Bullish
  7. EMA 5017037.02Bullish
  8. DEMA 1017321.13Bearish
  9. DEMA 2017221.12Bullish
  10. DEMA 5017170.82Bullish
  11. TEMA 1017366.27Bearish
  12. TEMA 2017293.04Bearish
  13. TEMA 5017104.60Bullish
  14. MACD83.69Bullish
  15. ADX27.38Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI59.58Neutral
  3. CCI90.26Neutral
  4. ROC 91.53Bullish
  5. ROC 143.28Bullish
  6. ROC 251.79Bullish
  7. Stoch K85.18Overbought
  8. Stoch D84.49Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper17474.83Neutral
  3. BB Middle17049.20Neutral
  4. BB Lower16623.57Neutral
  5. ATR215.84Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI71.65Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1017056.50Bullish
  3. SMA 2017061.40Bullish
  4. SMA 5016924.06Bullish
  5. EMA 1017126.59Bullish
  6. EMA 2017065.06Bullish
  7. EMA 5016790.47Bullish
  8. DEMA 1017212.99Bullish
  9. DEMA 2017158.68Bullish
  10. DEMA 5017488.51Bearish
  11. TEMA 1017271.25Bullish
  12. TEMA 2017153.86Bullish
  13. TEMA 50N/AN/A
  14. MACD76.34Bullish
  15. ADX21.83Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI57.14Neutral
  3. CCI104.34Overbought
  4. ROC 90.94Bullish
  5. ROC 142.20Bullish
  6. ROC 251.15Bullish
  7. Stoch K70.65Neutral
  8. Stoch D64.98Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper17399.59Neutral
  3. BB Middle17061.40Neutral
  4. BB Lower16723.21Neutral
  5. ATR334.04Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI66.68Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1017062.80Bullish
  3. SMA 2016989.00Bullish
  4. SMA 5016235.80Bullish
  5. SMA 10014558.28Bullish
  6. SMA 20015130.94Bullish
  7. EMA 1017072.64Bullish
  8. EMA 2016920.08Bullish
  9. EMA 5016161.58Bullish
  10. EMA 10015440.73Bullish
  11. EMA 20014820.93Bullish
  12. DEMA 1017179.92Bullish
  13. DEMA 2017307.51Bullish
  14. DEMA 5017273.18Bullish
  15. DEMA 10016315.51Bullish
  16. DEMA 20015920.33Bullish
  17. TEMA 1017187.48Bullish
  18. TEMA 2017118.86Bullish
  19. TEMA 5017761.80Bearish
  20. TEMA 10016943.95Bullish
  21. TEMA 20015811.17Bullish
  22. MACD267.02Bearish
  23. ADX23.82Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI60.50Neutral
  3. CCI139.20Overbought
  4. ROC 140.85Bullish
  5. ROC 253.99Bullish
  6. Stoch K64.13Neutral
  7. Stoch D50.35Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper17348.34Neutral
  3. BB Middle16989.00Neutral
  4. BB Lower16629.66Neutral
  5. ATR539.83Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.30Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2014423.40Bullish
  3. SMA 5014767.94Bullish
  4. EMA 2015342.62Bullish
  5. EMA 5014514.52Bullish
  6. DEMA 2016170.71Bullish
  7. DEMA 5015821.18Bullish
  8. TEMA 2016818.17Bullish
  9. TEMA 5015505.38Bullish
  10. MACD741.54Bullish
  11. ADX28.95Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI59.31Neutral
  3. CCI100.06Overbought
  4. ROC 1431.95Bullish
  5. ROC 257.19Bullish
  6. Stoch K81.30Overbought
  7. Stoch D79.29Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper18298.24Neutral
  3. BB Middle14423.40Neutral
  4. BB Lower10548.56Neutral
  5. ATR1283.67Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI74.28Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 614228.17Bullish
  3. SMA 1214372.58Bullish
  4. SMA 2413289.31Bullish
  5. EMA 614824.45Bullish
  6. EMA 1214188.22Bullish
  7. EMA 2412593.49Bullish
  8. DEMA 615448.93Bullish
  9. DEMA 1215429.57Bullish
  10. DEMA 2415816.36Bullish
  11. TEMA 615776.66Bullish
  12. TEMA 1215117.77Bullish
  13. TEMA 2415964.90Bullish
  14. MACD3519.04Bullish
  15. ADX52.96Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI64.49Neutral
  3. CCI115.37Overbought
  4. ROC 25125.04Bullish
  5. ROC 501560.40Bullish
  6. Stoch K63.23Neutral
  7. Stoch D70.69Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper17708.83Neutral
  3. BB Middle13890.58Neutral
  4. BB Lower10072.33Neutral
  5. ATR2592.59High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI66.71Neutral